Thesis - PhD (11)

221.
Thesis - PhD
Martin, C. E.: Chemical synthesis and biological evaluation of cell surface carbohydrate antigens for rational vaccine design. Dissertation, Freie Universität Berlin, Berlin (2014)

Working Paper (2)

222.
Working Paper
Michel, M.; Stijlemans, B.; Michel, D.; Garg, M.; Geißner, A.; Seeberger, P. H.; Varón Silva, D.: Detection of antibodies against the african parasite Trypanosoma brucei using synthetic glycosylphosphatidylinositol oligosaccharide fragments. bioRxiv: the preprint server for biology, 2023.12.31.573764 (2024)
223.
Working Paper
Pagel, K.; Chang, C.-W.; Greis, K.; Kirschbaum, C.; Leichnitz, S.; Meijer, G.; von Helden, G.; Seeberger, P. H.: Benzylidene-directed glycosylations – mechanistic insights from cryogenic infrared spectroscopy. Research Square (2023)

Other (1)

224.
Other
Seeberger, P. H.: How can vaccine design be modified by the use of synthetic sugars?, (2017)

Editorial (3)

225.
Editorial
Koksch, B.; Seeberger, P. H.: Editorial overview: synthetic biomolecules: biopolymers. Current Opinion in Chemical Biology 40, pp. A4 - A5 (2017)
226.
Editorial
Hicks, M. G.; Seeberger, P. H.; Seeberger, P. H.: The Beilstein Journal of Organic Chemistry and the changing face of scientific publishing. Beilstein Journal of Organic Chemistry 11, pp. 2242 - 2244 (2015)
227.
Editorial
Seeberger, P. H.; Werz, D. B.: Glycochemistry and glycobiology: a web themed issue. Chemical Communications 47 (45), p. 12259 - 12259 (2011)

Patent (24)

228.
Patent
Yin, J.; Hu, J.; Seeberger, P. H.; Qin, C.: Chemical synthesis method of plesiomonas shighelloides serotype O51 O-antigen oligosaccharide. (2019)
229.
Patent
Seeberger, P. H.: Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide. (2019)
230.
Patent
Yin, J.; Hu, J.; Seeberger, P. H.; Ye, Z.: Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation method. (2019)
231.
Patent
Seeberger, P. H.: Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as vaccines against Haemophilus influenzae type b. (2018)
232.
Patent
Seeberger, P. H.: Pneumococcal polysaccharide-protein conjugate composition. WO2017220753 (2018)
233.
Patent
Seeberger, P. H.; Pereira, C. L.; Parameswarappa, S. G.; Calow, A. D. J.; Menova, P.; Baek, J. Y.: Improved preparation of vaccines against Streptococcus pneumoniae type 3. (2017)
234.
Patent
Khan, N.; Emmadi, M.: Synthetic vaccines against Streptococcus pneumoniae serotype 2. (2017)
235.
Patent
Chakkumkal, A.; Lisboa, M.; Martin, C. E.; Pereira, C. L.; Seeberger, P. H.; Khan, N.: Vaccines against Streptococcus pneumoniae serotype 5. WO2016198170 (2016)
236.
Patent
Seeberger, P. H.; Pereira, C. L.; Xiao, G.; Khan, N.; Chakkumkal, A.: Vaccine against carbapenem-resistant klebsiella pneumoniae. EP3274358 (2016)
237.
Patent
Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Geißner, A.: Vaccines against Streptococcus pneumoniae serotype 4. EP3230297 (2016)
238.
Patent
Seeberger, P. H.; Martin, C. E.; Bröcker, F.; Chakkumkal, A.: Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
239.
Patent
Seeberger, P. H.; Pereira, C. L.; Chakkumkal, A.; Schumann, B.; Parameswarappa, S. G.; Hahm, H. S.; Govindan, S.: Synthetic vaccines against Streptococcus pneumoniae serotype 8. (2016)
240.
Patent
Seeberger, P. H.; Pereira, C. L.: Synthetic vaccines against Streptococcus pneumoniae. (2015)
Go to Editor View